Neutra (Neutra) 3-Year EBITDA Growth Rate : 0.00% (As of Oct. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Neutra 3-Year EBITDA Growth Rate?

Neutra's EBITDA per Share for the three months ended in Oct. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Neutra was 82.10% per year. The lowest was 43.60% per year. And the median was 58.55% per year.

Competitive Comparison of Neutra's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Neutra's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neutra's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neutra's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Neutra's 3-Year EBITDA Growth Rate falls into.

Neutra 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Neutra (OTCPK:NTRR) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Neutra 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Neutra's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Neutra (Neutra) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478

Website

https://www.neutrainc.com

Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.

Executives

Sydney Jim

director, officer: CEO & Chairman

8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243